1. Home
  2. ENTA vs BBBY Comparison

ENTA vs BBBY Comparison

Compare ENTA & BBBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.66

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

BBBY

Bed Bath & Beyond Inc.

HOLD

Current Price

$5.94

Market Cap

453.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
BBBY
Founded
1995
1971
Country
United States
United States
Employees
N/A
389
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.7M
453.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
BBBY
Price
$12.66
$5.94
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$20.40
$8.00
AVG Volume (30 Days)
172.5K
2.4M
Earning Date
05-11-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
$6.35
Revenue Next Year
N/A
$7.11
P/E Ratio
N/A
N/A
Revenue Growth
16.48
N/A
52 Week Low
$6.44
$4.26
52 Week High
$17.15
$12.65

Technical Indicators

Market Signals
Indicator
ENTA
BBBY
Relative Strength Index (RSI) 51.14 53.29
Support Level $11.92 $5.41
Resistance Level $13.97 $6.11
Average True Range (ATR) 0.79 0.48
MACD 0.13 -0.04
Stochastic Oscillator 73.47 42.22

Price Performance

Historical Comparison
ENTA
BBBY

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About BBBY Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering products and services that enable its customers to enhance everyday life through quality, style, and value. The company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites, as well as a blockchain asset portfolio. Its e-commerce platforms, www.bedbathandbeyond.com and www.overstock.com, are targeted at customers seeking various products such as furniture, bedding, area rugs, tabletop and cookware, decor, storage, jewelry, etc, at affordable prices. In addition to products, the company also offers add-on services across platforms, including warranties, shipping insurance, and installation services.

Share on Social Networks: